Open-Label Study of AG10 in Patients with Cardiomyopathy
Clinical trial NCT03536767 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03536767
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2027-07-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.